WATERTOWN, Mass.–(BUSINESS WIRE)–Mar 18, 2021– SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today reported full year 2020
WATERTOWN, Mass.–(BUSINESS WIRE)–Mar 18, 2021– SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today reported full year 2020